Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Transplantation ; 78(3): 324-32, 2004 Aug 15.
Article in English | MEDLINE | ID: mdl-15316358

ABSTRACT

BACKGROUND: Orthotopic liver transplantation (OLT) requires cold ischemic storage followed by warm reperfusion. Although c-Jun N-terminal kinase (JNK) is rapidly activated after OLT, the functional consequences of JNK activation are unknown. The aim of this study was to address the role of JNK after OLT using the selective JNK inhibitor CC-401. METHODS: Donors, recipients, or stored liver explants were treated with vehicle or JNK inhibitor before OLT by an arterialized two-cuff method with 40 hours of cold storage. Recipients were assessed for 30-day survival, and graft injury was assessed over time by hepatic histology, serum transaminases, caspase 3 activation, cytosolic cytochrome c, and lipid peroxidation. RESULTS: Survival after OLT increased after donor plus storage and storage only treatment with JNK inhibitor (P<0.05). Treatment of recipient only did not improve survival. Increased survival correlated with improved hepatic histology and serum aspartate aminotransferase levels. JNK inhibition significantly decreased nonparenchymal cell killing at 60 minutes after reperfusion (P<0.05) and pericentral necrosis at 8 hours after reperfusion (P<0.01). JNK inhibition decreased cytochrome c release, caspase 3 activation (P<0.05), and lipid peroxidation (P<0.05). JNK inhibition also transiently blocked phosphorylation of c-Jun at 60 minutes after reperfusion (P<0.05) without affecting other MAPK signaling, including p-38 and Erk activation. CONCLUSIONS: JNK inhibition decreases hepatic necrosis and apoptosis after OLT, suggesting that JNK activation promotes cell death by both pathways. Inhibition of JNK may be a new therapeutic strategy to prevent liver injury after transplantation.


Subject(s)
Apoptosis/physiology , Liver Transplantation/pathology , Liver/enzymology , Liver/injuries , Mitogen-Activated Protein Kinases/metabolism , Animals , Caspase 3 , Caspases/metabolism , JNK Mitogen-Activated Protein Kinases , Liver/pathology , Liver Transplantation/physiology , Male , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Necrosis , Pyrazolones/metabolism , Rats , Rats, Inbred Lew , Transplantation, Isogeneic , Tumor Necrosis Factor-alpha/metabolism
2.
Expert Opin Biol Ther ; 2(6): 621-32, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12171506

ABSTRACT

Altered gene expression contributes to the aetiology of inflammatory disease by modulation of the concentration of disease-related proteins. The expression of inflammatory genes is controlled through the concerted actions of specific transcription factors. Signal transduction networks positively or negatively regulate the activity of these transcription factors. Key components of these networks are protein kinases, which phosphorylate substrates on tyrosine, threonine or serine residues. During the disease process, pro-inflammatory signalling at the cell surface leads to a cascade of kinase activation, which ultimately culminates in modulation of the activity of transcription factors. Thus, pharmacological inhibition of protein kinases is a potential therapeutic strategy to treat inflammation. There are approximately 500 protein kinases in the human genome. Targeted small molecule inhibitors of these kinases should allow for tissue- and disease-specific therapies of unprecedented selectivity. Heralding this new era in molecular medicine is imatinib (Gleevec, Norvartis) a recently marketed tyrosine kinase inhibitor. This review focuses on kinase inhibitors that are currently in development for inflammatory diseases and the transcription factors that are involved.


Subject(s)
Enzyme Inhibitors/pharmacology , Inflammation/therapy , Phosphotransferases/antagonists & inhibitors , Transcription, Genetic , Animals , Drug Design , Gene Expression Regulation , Humans , Models, Biological , Models, Chemical , Phosphorylation , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...